Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a Health IT leader, integrating pharmacy dispensing AI platform EinsteinRx™ into patented pharmacy smart contracts platform PharmacyChain™, today provided a mid-year 2026 corporate outlook. The Company intends to focus on closing the recently announced DelivMeds AI transaction, continuing to drive quarter-over-quarter growth through its Wellgistics Pharmacy business unit, and supporting the continued progress in the three key aspects of the DelivMeds AI transaction: PharmacyChain™ progress, Medical Drones implementation and Health Lives Here launch scheduled for the third quarter of 2026.

Recent lock-up agreement to limit shares available for sale into the market

Exercise of warrants embedded in recent financing would provide funding through 2029